These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18986526)

  • 1. MetaFIND: a feature analysis tool for metabolomics data.
    Bryan K; Brennan L; Cunningham P
    BMC Bioinformatics; 2008 Nov; 9():470. PubMed ID: 18986526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis.
    Chong J; Wishart DS; Xia J
    Curr Protoc Bioinformatics; 2019 Dec; 68(1):e86. PubMed ID: 31756036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Multivariate Classification Models for Analyzing NMR Metabolomics Data.
    Vu T; Siemek P; Bhinderwala F; Xu Y; Powers R
    J Proteome Res; 2019 Sep; 18(9):3282-3294. PubMed ID: 31382745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional statistical recoupling for the identification of perturbed metabolic networks from NMR spectroscopy.
    Blaise BJ; Navratil V; Domange C; Shintu L; Dumas ME; Elena-Herrmann B; Emsley L; Toulhoat P
    J Proteome Res; 2010 Sep; 9(9):4513-20. PubMed ID: 20590164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel R-package graphic user interface for the analysis of metabonomic profiles.
    Izquierdo-García JL; Rodríguez I; Kyriazis A; Villa P; Barreiro P; Desco M; Ruiz-Cabello J
    BMC Bioinformatics; 2009 Oct; 10():363. PubMed ID: 19874601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance evaluation of algorithms for the classification of metabolic 1H NMR fingerprints.
    Hochrein J; Klein MS; Zacharias HU; Li J; Wijffels G; Schirra HJ; Spang R; Oefner PJ; Gronwald W
    J Proteome Res; 2012 Dec; 11(12):6242-51. PubMed ID: 23116257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis.
    Wang T; Shao K; Chu Q; Ren Y; Mu Y; Qu L; He J; Jin C; Xia B
    BMC Bioinformatics; 2009 Mar; 10():83. PubMed ID: 19291281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical assessment of feature selection methods for biomarker discovery in clinical proteomics.
    Christin C; Hoefsloot HC; Smilde AK; Hoekman B; Suits F; Bischoff R; Horvatovich P
    Mol Cell Proteomics; 2013 Jan; 12(1):263-76. PubMed ID: 23115301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overoptimism in cross-validation when using partial least squares-discriminant analysis for omics data: a systematic study.
    Rodríguez-Pérez R; Fernández L; Marco S
    Anal Bioanal Chem; 2018 Sep; 410(23):5981-5992. PubMed ID: 29959482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool.
    Zhang A; Zhou X; Zhao H; Guan Y; Zou S; Yan GL; Ma CW; Liu Q; Wang X
    Mol Biosyst; 2014 Aug; 10(8):2160-5. PubMed ID: 24889752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of chance correlations on variable selection using Partial Least Squares-Discriminant Analysis.
    Kuligowski J; Pérez-Guaita D; Escobar J; de la Guardia M; Vento M; Ferrer A; Quintás G
    Talanta; 2013 Nov; 116():835-40. PubMed ID: 24148482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1)H NMR-based metabolite profiling workflow to reduce inter-sample chemical shift variations in urine samples for improved biomarker discovery.
    Gil RB; Lehmann R; Schmitt-Kopplin P; Heinzmann SS
    Anal Bioanal Chem; 2016 Jul; 408(17):4683-91. PubMed ID: 27178551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.
    Deng L; Gu H; Zhu J; Nagana Gowda GA; Djukovic D; Chiorean EG; Raftery D
    Anal Chem; 2016 Aug; 88(16):7975-83. PubMed ID: 27437783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tutorial review: Metabolomics and partial least squares-discriminant analysis--a marriage of convenience or a shotgun wedding.
    Gromski PS; Muhamadali H; Ellis DI; Xu Y; Correa E; Turner ML; Goodacre R
    Anal Chim Acta; 2015 Jun; 879():10-23. PubMed ID: 26002472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive evaluation of untargeted metabolomics data processing software in feature detection, quantification and discriminating marker selection.
    Li Z; Lu Y; Guo Y; Cao H; Wang Q; Shui W
    Anal Chim Acta; 2018 Oct; 1029():50-57. PubMed ID: 29907290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing and analysis of GC/LC-MS-based metabolomics data.
    Want E; Masson P
    Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haystack, a web-based tool for metabolomics research.
    Grace SC; Embry S; Luo H
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S12. PubMed ID: 25350247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data processing, multi-omic pathway mapping, and metabolite activity analysis using XCMS Online.
    Forsberg EM; Huan T; Rinehart D; Benton HP; Warth B; Hilmers B; Siuzdak G
    Nat Protoc; 2018 Apr; 13(4):633-651. PubMed ID: 29494574
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.